Concurrent Investment Advisors LLC Sells 360 Shares of Danaher Co. (NYSE:DHR)

Concurrent Investment Advisors LLC reduced its stake in Danaher Co. (NYSE:DHR) by 9.5% during the 4th quarter, Holdings Channel reports. The fund owned 3,427 shares of the conglomerate’s stock after selling 360 shares during the period. Concurrent Investment Advisors LLC’s holdings in Danaher were worth $787,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently made changes to their positions in DHR. Heck Capital Advisors LLC bought a new position in shares of Danaher during the fourth quarter worth approximately $27,000. Decker Retirement Planning Inc. bought a new position in Danaher during the 4th quarter worth $31,000. Golden State Wealth Management LLC bought a new position in Danaher during the fourth quarter worth about $31,000. Strategic Financial Concepts LLC bought a new position in Danaher during the fourth quarter worth about $31,000. Finally, Pineridge Advisors LLC increased its position in Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after acquiring an additional 57 shares during the period. Institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling

In other news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 11.10% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research analysts have recently commented on DHR shares. StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Raymond James restated a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. Guggenheim assumed coverage on Danaher in a research note on Thursday, December 19th. They set a “buy” rating and a $275.00 price objective on the stock. Barclays decreased their price target on Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. Finally, Robert W. Baird decreased their price target on Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and a consensus target price of $278.00.

Danaher Stock Performance

Danaher stock opened at $209.86 on Monday. The business has a 50 day moving average of $226.71 and a 200-day moving average of $246.84. Danaher Co. has a 1 year low of $196.80 and a 1 year high of $281.70. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The company has a market capitalization of $151.58 billion, a P/E ratio of 39.75, a P/E/G ratio of 2.66 and a beta of 0.83.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the previous year, the company posted $2.09 earnings per share. On average, equities research analysts predict that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.61%. This is an increase from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio (DPR) is currently 20.45%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.